Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRAJ24 (T cell receptor alpha joining 24) is a genetic segment in the human TCRA locus encoding one of the joining (J) segments required for somatic recombination of the T cell receptor alpha (TCRα) chain[5]. During T cell development in the thymus, recombination between a variable (V) alpha segment and a J alpha segment, including TRAJ24, diversifies the antigen recognition site of the TCRα chain. TRAJ24 contributes to the CDR3 region of the TCR, which determines antigen specificity, but is not a receptor or protein with direct therapeutic relevance. The mature TCR complex consisting of TCRα and TCRβ chains (and associated CD3 and coreceptor molecules) is the functional surface heterodimer responsible for antigen recognition and T cell activation[1][2][4][6]. TRAJ24 is not a mature receptor, enzyme, transporter, or standalone protein—it is only functional as part of the assembled TCRα polypeptide. Summary of correctness: - TRAJ24 is a gene segment, not a molecular target or whole protein[5][1]. - The relevant drug target is the mature T cell receptor (TCR), not any individual V, D, or J segment. - This entry is not a therapeutic target by standard pharmacological or biological criteria.
null (not directly targetable—mechanisms are only relevant at the level of the mature TCR complex)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T cell receptor alpha joining 24 (TRAJ24).